Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SeraNovo, Équilibre BioPharma Expand Alliance | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

SeraNovo, Équilibre BioPharma Expand Alliance

License agreement aims to progress another poorly water soluble drug candidate into the clinic using SeraNovo's deep eutectic solvent formulation platform.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

SeraNovo BV based in Leiden, The Netherlands, entered a License Agreement with Équilibre BioPharmaceuticals Corp. in New York, a biopharmaceutical company developing small molecules in the field of neuroscience. Under the agreement, the companies will expand their existing collaboration and jointly develop a breakthrough product.
 
Niall Hodgins, Chief Executive Officer of SeraNovo said, “We are thrilled to enter into this license agreement with Équilibre and progress another poorly water soluble drug candidate into the clinic using our deep eutectic solvent formulation platform. This agreement is a great step to broaden our customer base in North America and into the neurology field. SeraNovo are looking forward to many fruitful collaborations in these important markets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics